News & Highlights
Speaker Application
If you wish to speak at the World Medical Innovation Forum or know someone that does, please follow the application form and we will be sure to respond if we think you’re a good fit.
National Suicide Prevention Month: Using AI to enhance precision psychiatry
September is recognized as National Suicide Prevention Month, a time dedicated to raising awareness about the prevalence of suicide and its devastating impact on individuals
The American Healthcare landscape in collaboration with Artificial Intelligence — an interview with Sree Chaguturu, MD, CVS Health
Sree Chaguturu, MD, Executive Vice President and Chief Medical Officer at CVS Health, joined Mass General Brigham and Bank of America at the 2023 World
Perspectives from the World Medical Innovation Forum: Progress in Innovation for the Neurodegenerative Disease Community
Complexities and considerations in drug development for neurological diseases Among the most challenging drugs to develop are drugs that target the brain. Yet, they signify
ARPA-H: Pioneering a Fresh Frontier in Healthcare Research and Innovation
The Advanced Research Project Agency for Health (ARPA-H), is a new federal endeavor that tackles high-payoff research — a new agency taking a fresh approach
The Inflation Reduction Act, What’s Next? At the World Medical Innovation Forum
Pictured left to right, Tom Hubbard, Senior Vice President of the Network for Excellence in Health Innovation (NEHI), Peter Neumann, ScD, Director, Center for the
First Look — Delivering on the promise of immunotherapy for the treatment of brain cancer
The Artzi lab is designing biomaterials that enhance precise drug delivery to enhance therapeutic outcomes in a range of diseases.
First Look — Untangling the role of rare genetic variants in protection against Alzheimer’s disease: From biomarkers to novel therapeutic targets
For the past two decades, Dr. Quiroz and the Mass General Familial Dementia Neuroimaging Lab have followed an extended family of 6,000 individuals with a known Alzheimer’s disease (AD) genetic mutation, PSEN1 E280A.
New Publication from Bank of America Institute Highlights Disruptive Dozen: Top 12 Emerging Healthcare Technologies
Breakthroughs range from obesity drugs and diabetes treatment to potential new therapies for ALS and a future blood test for Alzheimer’s Disease Last week, Bank
Coming Soon to a Clinic Near You: Top 12 Emerging Technologies Likely to Impact Patient Care Announced in Annual “Disruptive Dozen” from Mass General Brigham
Breakthroughs range from obesity drugs and diabetes treatment to potential new therapies for ALS and a future blood test for Alzheimer’s Disease BOSTON, MA –
